Word: journalism
(lookup in dictionary)
(lookup stats)
Dates: during 1980-1989
Sort By: most recent first
(reverse)
...respected researcher who was one of the first to use cyclosporine may have found a better way to make transplants succeed. Dr. Thomas Starzl of the University of Pittsburgh, the world's largest transplant center, is expected to report in the British journal Lancet this week that a new drug, FK-506, is proving to be more powerful and less toxic than cyclosporine. In more than 100 patients taking FK-506 for up to eight months, the rate of organ rejection was only one-sixth as high as in those using cyclosporine. Side effects were minimal, though long-term consequences...
...said he plans to enter this year's competition, finished 92nd last year with $766,000--a 53.2 percent increase over his original investments. Kidd, an economics concentrator, said he put his money in five or six different stocks at a time, selecting companies by reading The Wall Street Journal and listening to "anything you'd hear from anybody...
...begin your pre-interview research in the OCS library. Useful directories include Standard & Poor's Register of Corporations, Directors and Executives, and Dunn and Bradstreet's Reference Book of Corporate Managements. We also get Business Week, Fortune and The Wall Street Journal. We also have a collection of the annual reports of recruiting companies...
...accurately portrayed, financial collusion at the expense of students, faculty and other employees is a most illiberal, exploitative practice amounting to millions of dollars. But since the inquiry was made public by The Wall Street Journal and other media heavy-weights in August, a lot of documents, press releases, legalistic arguments and philosophical points have been bandied about. The massive and unprecedented Justice Department review will likely take months to clear the confusion...
...cancer patients, most of whom had been operated on for Dukes' C colon cancer. In this stage of the cancer, the tumor has penetrated the bowel wall but has not spread to the rest of the body. The results of the first study, which appeared in this month's Journal of Clinical Oncology, showed that 49% of patients receiving the treatment were still alive after five years, in contrast to 37% of another group that did not receive the drugs. In a second and much larger study, which has yet to be published, the benefit from the drug therapy...